Abstract
A 74-year-old man presented with persistent metamorphopsias of the right eye 2 weeks after intravitreal injection of bevacizumab to treat choroidal neovascularization due to exudative age-related macular degeneration. The diagnosis reached was retinochoroiditis as an occult manifestation of sarcoidosis, possibly resulting from an intravitreal injection of bevacizumab. The patient received a prescription for 100 mg Ultralan to be taken daily for 3 days and then tapered in 3 day steps. During the further course no deterioration of the condition was observed.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Aged
-
Angiogenesis Inhibitors / administration & dosage
-
Angiogenesis Inhibitors / adverse effects
-
Anti-Inflammatory Agents / therapeutic use
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal, Humanized
-
Bevacizumab
-
Chorioretinitis / chemically induced*
-
Chorioretinitis / diagnosis
-
Chorioretinitis / drug therapy*
-
Fluocortolone / therapeutic use*
-
Humans
-
Injections, Intralesional
-
Male
-
Treatment Outcome
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors*
-
Vitreous Body
Substances
-
Angiogenesis Inhibitors
-
Anti-Inflammatory Agents
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Vascular Endothelial Growth Factor A
-
Bevacizumab
-
Fluocortolone